Ophthalmic Eye Drops Franchise in Ahmedabad

Antibiotic Steroid Eye Drops Supplier in Mumbai

Eye Infection Treatment Drops Distributor in Delhi

Ophthalmic Product Manufacturer in Bangalore

Eye Care Medicine Stockist in Hyderabad
Ophthalmic Product Exporter in Chandigarh

Home/Products /moxifloxacin-0-point-5-w-v-difluprednate-0-point-05-w-v-eye-ear-drop

Moxolunic DF Eye Drops

Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹120/-

Moxifloxacin 0.5% + Difluprednate 0.05% Eye Drops are indicated for the treatment of bacterial eye infections accompanied by moderate to severe inflammation, including postoperative ocular conditions.

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic that effectively eliminates causative bacteria, while difluprednate is a powerful corticosteroid that rapidly reduces inflammation, pain, redness, and swelling.

This advanced combination is widely prescribed in infective-inflammatory ocular disorders where strong anti-inflammatory action along with reliable antibacterial coverage is clinically essential.

With its fast symptom relief and high therapeutic reliability, this formulation encourages repeat prescriptions, strengthens treatment outcomes, and helps build a loyal customer base by consistently meeting ophthalmic care expectations.

Read More

About the Product

Moxifloxacin 0.5% + Difluprednate 0.05% Eye Drops are indicated for the treatment of bacterial eye infections accompanied by moderate to severe inflammation, including postoperative ocular conditions.

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic that effectively eliminates causative bacteria, while difluprednate is a powerful corticosteroid that rapidly reduces inflammation, pain, redness, and swelling.

This advanced combination is widely prescribed in infective-inflammatory ocular disorders where strong anti-inflammatory action along with reliable antibacterial coverage is clinically essential.

With its fast symptom relief and high therapeutic reliability, this formulation encourages repeat prescriptions, strengthens treatment outcomes, and helps build a loyal customer base by consistently meeting ophthalmic care expectations.

Common side effects may include transient eye irritation, burning sensation, blurred vision, or redness. Rarely, prolonged use may lead to increased intraocular pressure, delayed wound healing, cataract formation, or secondary infections.

Moxolunic DF Eye Drops are indicated for severe steroid-responsive inflammatory ocular conditions with suspected or confirmed bacterial infection, including post-operative eye inflammation, uveitis, conjunctivitis, and other bacterial eye infections as advised by an ophthalmologist.

For ophthalmic use only. Use strictly under medical supervision. Avoid touching the dropper tip to prevent contamination. Prolonged or inappropriate use may increase the risk of glaucoma or other steroid-related complications. Discontinue use and consult an eye specialist if severe irritation or vision changes occur.

Store below 25°C in a cool, dry place. Protect from light. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation